HAO ZHANG Partner Fangda Partners +86 21 6263 5917 [email protected]

PRACTICE AREAS MR. HAO ZHANG SPECIALIZES IN M&A, PRIVATE EQUITY INVESTMENT, FOREIGN DIRECT INVESTMENT, AND GENERAL CORPORATE MATTERS.

REPRESENTATIVE MATTERS AND CASES

Represented SoftBank Vision Fund in its investment in Didi Chuxing, one of the largest app-based transportation companies headquartered in Represented SoftBank Vision Fund in its investment in the China piece of OYO Rooms, the world’s third-largest and fastest-growing hospitality chain of leased and franchised hotels and homes Represented SoftBank Vision Fund in series D+ investment in Beike, a leading app-based real estate brokerage service and provider in China Represented SoftBank Vision Fund in its Series C investment in Ziroom, a leading service provider of long- and short-term lease of renovated apartments Represented Yunfeng Capital in its equity investment in a China internet- based brokerage service provider Represented TPG Capital in its proposed investment in a domestic e- commerce logistics company in Represented Colgate-Palmolive in its proposed acquisition of 75% equity interest in a leading personal oral care company in China Represented Nouryon (formally AkzoNobel Specialty Chemical) in its acquisition of a China-based chemical product manufacturer

1 Represented Axalta Coating Systems in its acquisition of a China-based coatings company Represented Pall Corporation, a subsidiary of Danaher Corporation, in its disposal of water purification system businesses Represented Jamieson Laboratories, one of the largest nutritional food manufacturers and distributors in Canada, in its joint venture in China Represented VMware in its investment in and business operation with a domestic cloud solution provider in China Represented a California-based biotech company in its joint venture in China for CAR-T immunotherapies treatment business Represented Morgan Stanley Real Estate Fund in its indirect acquisition of a logistics park in Dongguan through its direct acquisition of a warehousing company in Dongguan Represented GLP in its indirect acquisition of a logistics real property in Tianjin Free Trade Zone through its direct acquisition of a logistics company in Tianjin Represented KHI Overseas Limited in its indirect acquisition of Crystal Galleria, a Grade-A office tower in Jing’an District, Shanghai, through its direct acquisition of a majority interest in an offshore subsidiary of Shenzhen World Union (002285.SZ) Represented China National Biotech Group in its proposed bid to acquire a leading Israel-based aesthetic medical device manufacturer Represented a Beijing-based private equity firm in its proposed $148 million asset acquisition of the physical vapor deposition business unit of Praxair, Inc.

OTHER INFORMATION

Education

Fudan University School of Law, LL.B., 2009 New York University School of Law, LL.M., 2015

Professional Qualification

Admitted to practice in the PRC Admitted to practice in New York

Professional Background

2 Mr. Zhang joined the firm in 2019. Before joining Fangda, Mr. Zhang worked at several leading international and PRC law firms in their Shanghai and Beijing offices.

3